Health care index score and risk of death following tuberculosis diagnosis in HIV-positive patients

International Journal of Tuberculosis and Lung Disease

Volumn 17, Issue 2, 2013, Pages

  Podlekareva, Daria N ^a   Grint, D ^b   Post, F A ^c,v   Mocroft, A ^b   Panteleev, A M ^d   Miller, R F ^b,t   Miro, J M ^e   Bruyand, M ^f,q   Furrer, H ^g,p   Riekstina, V ^h,w   Girardi, E ⁱ   Losso, M H ^j,r   Cayla J A ^k   Malashenkov, E A ^l   Obel, N ^m,u   Skrahina, A M ^n,x   Lundgren, J D ^a,l,s   Kirk, O ^a,l   Chentsova, N ^o   Duiculesku, D ^r,r   Toibaro, J J ^r   Warley, E ^r   Tamayo, N ^r   Ortiz, M C ^r   Scapelatto, P ^r   Bottaro, E ^r   Murano, F ^r   Miachans, M ^r   Contarelli, J ^r   Massera, L ^r   Corral, J ^r   Hualde, M ^r   Miglioranza, C ^r   Corti, M ^r   Metta, H ^r   Casiro A ^r   Cuini, R ^r   Laplume, H ^r   David, D ^r   Marson, C ^r   Lupo, S ^r   Trape, L ^r   Garcia Messina, O ^r   Gear, O ^r   Bruguera, J M ^r   Karpov, I ^r   Vasilenko, A ^r   Skrahina, E ^r   Mitsura, V ^r   Kozorez, E ^r   Ruzanov, D ^r   Bondarenko, V ^r   Suetnov, O ^r   Paduto, D ^r   Dabis, F ^r   Matteelli, A ^r   Carvalho, A C ^r   Basche R ^r   Hamad, I E ^r   Ricci, B A ^r   Maggiolo, F ^r   Ravasio, V ^r   Mussini, C ^r   Prati, F ^r   Castelletti, S ^r   Spallanzani, L ^r   Antinori, A ^r   Antonucci, G ^r   Bibbolino, C ^r   Bove, G ^r   Busi Rizzi, E ^r   Cicalini, S ^r   Conte, A ^r   Cuzzi, G ^r   De Mori, P ^r   Festa, A ^r   Goletti, D ^r   Grisetti, S ^r   Gualano, G ^r   Lauria, F N ^r   Maddaluno, R ^r   Migliorisi Ramazzini, P ^r   Narciso, P ^r   Parracino, L ^r   Palmieri, F ^r   Petrosillo, N ^r   Pucillo, L ^r   Puro, V ^r   Vanacore, P ^r   Urso, R ^r   Aldins, P ^r   Zeltina, I ^r   Duiculescu, D ^r   Rakhmanova, A ^r   Kozlov, A ^r   Buzunova, S ^r   Manzardo, C ^r   Garcia Goez J F ^r   Moreno Camacho, A ^r   Martinez J A ^r   Gonzalez J ^r   Garcia Alcaide F ^r   Perez I ^r   Gatell, J M ^r   Sanchez P ^r   Lopez Colomes Mutua de Terrassa J L ^r   Martinez Lacasa X ^r   Imaz, V F ^r   Ocana I ^r   Vidal, R ^r   Sambeat, M A ^r   Moreno Martinez A ^r   Millet, J P ^r   Fina, L ^r   del Bano L ^r   Orcau, A ^r   Barth, J ^r   Battegay, M ^r   Bernasconi, E ^r   Boni J ^r   Bucher, H C ^r   Burton Jeangros, C ^r   Calmy, A ^r   Cavassini, M ^r   Cellerai, C ^r   Egger, M ^r   Elzi, L ^r   Fehr, J ^r   Fellay, J ^r   Flepp, M ^r   Fux, C A ^r   Gorgievski, M ^r   Gunthard H ^r   Haerry, D ^r   Hasse, B ^r   Hirsch, H H ^r   Hirschel, B ^r   Hosli I ^r   Kahlert, C ^r   Kaiser, L ^r   Keiser, O ^r   Kind, C ^r   Klimkait, T ^r   Kovari, H ^r   Ledergerber, B ^r   Martinetti, G ^r   Martinez de Tejada, B ^r   Metzner, K ^r   Muller N ^r   Nadal, D ^r   Pantaleo, G ^r   Rauch, A ^r   Regenass, S ^r   Rickenbach, M ^r   Rudin, C ^r   Schmid, P ^r   Schultze, D ^r   Schoni Affolter F ^r   Schupbach J ^r   Speck, R ^r   Taffe P ^r   Tarr, P ^r   Telenti, A ^r   Trkola, A ^r   Vernazza, P ^r   Weber, R ^r   Yerly, S ^r   Campbell, L ^r   Arenas Pinto, A ^r   Kjaer J ^r   Ellefson, M ^r   more..

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d TB Hospital 2   (Russian Federation)

^e UNIVERSITY OF BARCELONA   (Spain)

^f INSERM   (France)

^g UNIVERSITY OF BERN   (Switzerland)

^h Infectology Centre of Latvia   (Latvia)

ⁱ NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^j HOSPITAL RAMOS MEJÍA   (Argentina)

^k CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^l Botkin Hospital of Infectious Diseases   (Russian Federation)

^m Rigshospitalet   (Denmark)

ⁿ Institute of Pulmonology and Tuberculosis   (Belarus)

^o Kiev City AIDS Centre   (Ukraine)

^p Swiss HIV Cohort   (Switzerland)

^q Aquitaine cohort   (France)

^r Swiss HIV Cohort ^*

^s EuroSIDA cohort   (France)

^t Danish HIV Cohort   (France)

^u Danish HIV Cohort   (Denmark)

^v KING S COLLEGE HOSPITAL   (United Kingdom)

^w State Ctr of TB and Lung Diseases   (Latvia)

^x Republican Research and Practical Center for Pulmonology and Phthisiology   (United Kingdom)

more..

Author keywords

Health care index score; Outcome of TB HIV patients; TB HIV co infection; TB HIV health care utilisation

Indexed keywords

ANTIRETROVIRUS AGENT; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN;

ANTIBIOTIC SENSITIVITY; ARGENTINA; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; EASTERN EUROPE; EUROPE; FEMALE; HEALTH CARE INDEX SCORE; HEALTH CARE UTILIZATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MORTALITY; MULTIVARIATE ANALYSIS; NORTHERN EUROPE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROBABILITY; PROGNOSIS; RISK ASSESSMENT; SCORING SYSTEM; SOUTHERN EUROPE; STATISTICAL MODEL; TUBERCULOSIS;

EID: 84872313596     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.12.0224     Document Type: Article

References (30)

1. Kaplan J E, Benson C, Holmes K H, Brooks J T, Pau A, Masur H. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep 2009; 58 (RR-4): 1-207.
2. Pozniak A L, Coyne K M, Miller R F, Lipman M C, Freedman A R, Ormerod L P. British HIV Association guidelines for the treatment of TB/HIV co-infection 2011. London, UK: BHIVA, 2012. http://www.bhiva.org/documents/Guidelines/TB/hiv- 954-online-final.pdf Accessed October 2012.
3. World Health Organization. Global tuberculosis control: epidemiology, strategy, financing. WHO report 2009. WHO/HTM/TB/2009.411. Geneva, Switzerland: WHO, 2009. http://www.who.int/tb/publications/global-report/2009/en/index.html Accessed October 2012.
4. Gandhi N R, Nunn P, Dheda K, et al. Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis. Lancet 2010; 375: 1830-1843.
5. Dheda K, Shean K, Zumla A, et al. Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: a retrospective cohort study. Lancet 2010; 375: 1798-1807.
6. Podlekareva D N, Mocroft A, Post F A, et al. Mortality from HIV and TB coinfections is higher in Eastern Europe than in Western Europe and Argentina. AIDS 2009; 23: 2485-2495.
7. Dye C, Espinal M A, Watt C J, Mbiaga C, Williams B G. Worldwide incidence of multidrug-resistant tuberculosis. J Infect Dis 2002; 185: 1197-1202. (Pubitemid 34297782)
8. Seung K J, Omatayo D B, Keshavjee S, Furin J J, Farmer P E, Satti H. Early outcomes of MDR-TB treatment in a high HIV-prevalence setting in southern Africa. PLoS ONE 2009; 4: e7186.
9. Mulissa Z, Jerene D, Lindtjorn B. Patients present earlier and survival has improved, but pre-ART attrition is high in a sixyear HIV cohort data from Ethiopia. PLoS ONE 2010; 5: e13268.
10. Centers for Disease Control. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 1992; 41 (RR-17): 1-19.
11. Rieder H L, Watson J M, Raviglione M C, et al. Surveillance of tuberculosis in Europe. Recommendations of a Working Group of the World Health Organization (WHO) and the European Region of the International Union Against Tuberculosis and Lung Disease (IUATLD) for uniform reporting on tuberculosis cases. Eur Respir J 1996; 9: 1097-1104.
12. Worodria W, Massinga-Loembe M, Mazakpwe D, et al. Incidence and predictors of mortality and the effect of tuberculosis immune reconstitution inflammatory syndrome in a cohort of TB/HIV patients commencing antiretroviral therapy. J Acquir Immune Defic Syndr 2011; 58: 32-37.
13. Getahun H, Harrington M, O'Brien R, Nunn P. Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes. Lancet 2007; 369: 2042-2049. (Pubitemid 46908825)
14. Hudson C P, Wood R, Maartens G. Diagnosing HIV-associated tuberculosis: reducing costs and diagnostic delay. Int J Tuberc Lung Dis 2000; 4: 240-245. (Pubitemid 30151572)
15. Monkongdee P, McCarthy K D, Cain K P, et al. Yield of acid-fast smear and mycobacterial culture for tuberculosis diagnosis in people with human immunodeficiency virus. Am J Respir Crit Care Med 2009; 180: 903-908.
16. Colebunders R, Bastian I. A review of the diagnosis and treatment of smear-negative pulmonary tuberculosis. Int J Tuberc Lung Dis 2000; 4: 97-107. (Pubitemid 30123641)
17. Boehme C C, Nabeta P, Hillemann D, et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med 2010; 363: 1005-1015.
18. Helb D, Jones M, Story E, et al. Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology. J Clin Microbiol 2010; 48: 229-237.
19. Blakemore R, Story E, Helb D, et al. Evaluation of the analytical performance of the Xpert MTB/RIF assay. J Clin Microbiol 2010; 48: 2495-2501.
20. Wilson D, Nachega J B, Chaisson R E, Maartens G. Diagnostic yield of peripheral lymph node needle-core biopsies in HIV-infected adults with suspected smear-negative tuberculosis. Int J Tuberc Lung Dis 2005; 9: 220-222. (Pubitemid 40278388)
21. von Reyn C F. The significance of bacteremic tuberculosis among persons with HIV infection in developing countries. AIDS 1999; 13: 2193-2195.
22. World Health Organization. Treatment of tuberculosis: guidelines. 4th ed. WHO/HTM/TB/2009.420. Geneva, Switzerland: WHO, 2009. http://whqlibdoc.who.int/ publications/2010/9789241547833-eng.pdf Accessed October 2012.
23. Saukkonen J J, Cohn D L, Jasmer R M, et al. An official ATS statement: hepatotoxicity of antituberculosis therapy. Am J Respir Crit Care Med 2006; 174: 935-952. (Pubitemid 44564795)
24. Abdool Karim S S, Naidoo K, Grobler A, et al. Timing of initiation of antiretroviral drugs during tuberculosis therapy. N Engl J Med 2010; 362: 697-706.
25. Abdool Karim S S, Naidoo K, Grobler A, et al. Integration of antiretroviral therapy with tuberculosis treatment. N Engl J Med 2011; 365: 1492-1501.
26. Havlir D V, Kendall M A, Ive P, et al. Timing of antiretroviral therapy for HIV-1 infection and tuberculosis. N Engl J Med 2011; 365: 1482-1491.
27. Blanc F X, Sok T, Laureillard D, et al. Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis. N Engl J Med 2011; 365: 1471-1481.
28. Donoghoe M C, Bollerup A R, Lazarus J V, Nielsen S, Matic S. Access to highly active antiretroviral therapy (HAART) for injecting drug users in the WHO European Region 2002-2004. Int J Drug Policy 2007; 18: 271-280. (Pubitemid 47126280)
29. Lawn S D, Harries A D, Wood R. Strategies to reduce early morbidity and mortality in adults receiving antiretroviral therapy in resource-limited settings. Curr Opin HIV AIDS 2010; 5: 18-26.
30. Havlir D V, Getahun H, Sanne I, Nunn P. Opportunities and challenges for HIV care in overlapping HIV and TB epidemics. JAMA 2008; 300: 423-430. (Pubitemid 352040254)